Bbva Compass Bancshares Inc. Takes $294,000 Position in Elanco Animal Health (ELAN)

Bbva Compass Bancshares Inc. purchased a new stake in shares of Elanco Animal Health (NASDAQ:ELAN) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 9,156 shares of the company’s stock, valued at approximately $294,000.

Several other hedge funds have also recently added to or reduced their stakes in the business. South Dakota Investment Council purchased a new position in shares of Elanco Animal Health in the 1st quarter valued at approximately $441,000. California Public Employees Retirement System raised its position in shares of Elanco Animal Health by 11,658.8% in the 1st quarter. California Public Employees Retirement System now owns 1,210,218 shares of the company’s stock valued at $38,812,000 after purchasing an additional 1,199,926 shares during the last quarter. State Board of Administration of Florida Retirement System raised its position in shares of Elanco Animal Health by 665.5% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 703,072 shares of the company’s stock valued at $22,548,000 after purchasing an additional 611,225 shares during the last quarter. Greenwood Capital Associates LLC purchased a new position in shares of Elanco Animal Health in the 1st quarter valued at approximately $292,000. Finally, Gabelli Funds LLC purchased a new position in shares of Elanco Animal Health in the 1st quarter valued at approximately $1,791,000.

Several equities analysts recently commented on ELAN shares. Morgan Stanley started coverage on shares of Elanco Animal Health in a research report on Wednesday, March 13th. They issued an “equal weight” rating and a $34.00 price objective for the company. UBS Group started coverage on shares of Elanco Animal Health in a research report on Wednesday, January 23rd. They issued a “sell” rating and a $29.00 price objective for the company. William Blair started coverage on shares of Elanco Animal Health in a research report on Monday, February 11th. They issued a “market perform” rating and a $29.71 price objective for the company. Bank of America raised shares of Elanco Animal Health from a “neutral” rating to a “buy” rating and set a $30.95 price objective for the company in a research report on Monday, March 18th. Finally, Zacks Investment Research raised shares of Elanco Animal Health from a “hold” rating to a “buy” rating and set a $37.00 price objective for the company in a research report on Tuesday, March 26th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $33.47.

In other Elanco Animal Health news, Director R David Hoover purchased 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, March 13th. The shares were bought at an average price of $31.43 per share, for a total transaction of $628,600.00. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director John P. Bilbrey purchased 7,750 shares of the business’s stock in a transaction that occurred on Monday, May 13th. The stock was acquired at an average price of $32.39 per share, for a total transaction of $251,022.50. The disclosure for this purchase can be found here.

Shares of NASDAQ:ELAN opened at $33.00 on Friday. Elanco Animal Health has a twelve month low of $28.00 and a twelve month high of $37.61.

Elanco Animal Health (NASDAQ:ELAN) last issued its quarterly earnings results on Thursday, May 9th. The company reported $0.25 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.22 by $0.03. The business had revenue of $731.10 million during the quarter, compared to analyst estimates of $743.40 million. During the same quarter last year, the company posted $0.33 EPS. Elanco Animal Health’s quarterly revenue was down .7% compared to the same quarter last year.

TRADEMARK VIOLATION NOTICE: “Bbva Compass Bancshares Inc. Takes $294,000 Position in Elanco Animal Health (ELAN)” was originally posted by Stock Observer and is owned by of Stock Observer. If you are accessing this piece of content on another site, it was copied illegally and republished in violation of United States & international copyright laws. The legal version of this piece of content can be read at https://www.thestockobserver.com/2019/05/17/bbva-compass-bancshares-inc-takes-294000-position-in-elanco-animal-health-elan.html.

About Elanco Animal Health

There is no company description available for Elanco Animal Health Inc

Featured Article: How Does the Quiet Period Work?

Want to see what other hedge funds are holding ELAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elanco Animal Health (NASDAQ:ELAN).

Institutional Ownership by Quarter for Elanco Animal Health (NASDAQ:ELAN)

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.